Abstract
Management of Complete Hydatidiform Mole with Co-existing Fetus
Highlights
Complete hydatidiform mole with co-existing fetus (CHMCF) is a rare obstetrical finding, only occurring in 1 per 20,000 to 100,000 pregnancies [1,2,3,4,5]
These pregnancies pose a unique set of health concerns including hemorrhage, thyrotoxicosis, preeclampsia, and gestational trophoblastic neoplasia (GTN)
Pregnancies complicated by CHMCF are rare, and as a result, there is a paucity of literature to help guide management
Summary
Complete hydatidiform mole with co-existing fetus (CHMCF) is a rare obstetrical finding, only occurring in 1 per 20,000 to 100,000 pregnancies [1,2,3,4,5]. Complete hydatidiform mole with co-existing fetus (CHMCF) is a rare obstetrical finding. Further follow-up revealed a complete hydatidiform mole with co-existing fetus in a patient who desired continuation of pregnancy.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
